- Home
- CRVS vs MCFT Comparison
CRVS vs MCFT Comparison
Compare CRVS & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- MCFT
- Stock Information
- Founded
- CRVS 2014
- MCFT 1968
- Country
- CRVS United States
- MCFT United States
- Employees
- CRVS N/A
- MCFT N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- MCFT Marine Transportation
- Sector
- CRVS Health Care
- MCFT Industrials
- Exchange
- CRVS Nasdaq
- MCFT Nasdaq
- Market Cap
- CRVS 305.4M
- MCFT 315.8M
- IPO Year
- CRVS 2016
- MCFT 2015
- Fundamental
- Price
- CRVS $5.75
- MCFT $21.94
- Analyst Decision
- CRVS Strong Buy
- MCFT Hold
- Analyst Count
- CRVS 4
- MCFT 6
- Target Price
- CRVS $15.00
- MCFT $21.50
- AVG Volume (30 Days)
- CRVS 518.7K
- MCFT 161.0K
- Earning Date
- CRVS 08-07-2025
- MCFT 08-27-2025
- Dividend Yield
- CRVS N/A
- MCFT N/A
- EPS Growth
- CRVS N/A
- MCFT N/A
- EPS
- CRVS N/A
- MCFT 0.43
- Revenue
- CRVS N/A
- MCFT $284,203,000.00
- Revenue This Year
- CRVS N/A
- MCFT $15.58
- Revenue Next Year
- CRVS N/A
- MCFT $4.25
- P/E Ratio
- CRVS N/A
- MCFT $33.75
- Revenue Growth
- CRVS N/A
- MCFT N/A
- 52 Week Low
- CRVS $2.54
- MCFT $14.39
- 52 Week High
- CRVS $10.00
- MCFT $23.50
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- MCFT 60.94
- Support Level
- CRVS $5.28
- MCFT $20.83
- Resistance Level
- CRVS $5.64
- MCFT $23.50
- Average True Range (ATR)
- CRVS 0.30
- MCFT 0.82
- MACD
- CRVS 0.03
- MCFT 0.18
- Stochastic Oscillator
- CRVS 77.70
- MCFT 60.61
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About MCFT MasterCraft Boat Holdings Inc.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.